Success Metrics

Clinical Success Rate
92.3%

Based on 12 completed trials

Completion Rate
92%(12/13)
Active Trials
3(14%)
Results Posted
67%(8 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_1
1
5%
Ph phase_2
3
14%
Ph not_applicable
7
33%
Ph phase_4
10
48%

Phase Distribution

1

Early Stage

3

Mid Stage

10

Late Stage

Phase Distribution21 total trials
Phase 1Safety & dosage
1(4.8%)
Phase 2Efficacy & side effects
3(14.3%)
Phase 4Post-market surveillance
10(47.6%)
N/ANon-phased studies
7(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.6%

12 of 17 finished

Non-Completion Rate

29.4%

5 ended early

Currently Active

3

trials recruiting

Total Trials

21

all time

Status Distribution
Active(4)
Completed(12)
Terminated(5)

Detailed Status

Completed12
Withdrawn4
Recruiting3
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
3
Success Rate
92.3%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (4.8%)
Phase 23 (14.3%)
Phase 410 (47.6%)
N/A7 (33.3%)

Trials by Status

withdrawn419%
recruiting314%
completed1257%
enrolling_by_invitation15%
terminated15%

Recent Activity

3 active trials
Showing 5 of 21
terminatedphase_4

Comparison of Potassium Binders in the ER

NCT04585542
completedphase_4

Pre-operative Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery

NCT06159777
enrolling_by_invitationphase_2

Polyethylene-glycol Assisted Nerve Repair in Phalloplasty

NCT05897086
completedphase_4

Bowel Function After Minimally Invasive Hysterectomy

NCT04263896
recruitingphase_4

Preop Laxatives in Robotic Urologic Surgery

NCT05805436
View all 21 trials

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT04585542Phase 4

Comparison of Potassium Binders in the ER

Terminated
NCT06159777Phase 4

Pre-operative Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery

Completed
NCT05897086Phase 2

Polyethylene-glycol Assisted Nerve Repair in Phalloplasty

Enrolling By Invitation
NCT04263896Phase 4

Bowel Function After Minimally Invasive Hysterectomy

Completed
NCT05805436Phase 4

Preop Laxatives in Robotic Urologic Surgery

Recruiting
NCT06825260Phase 4

PEG3350 vs Senna After Urogyn Surgery

Recruiting
NCT04210427Phase 4

Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit

Completed
NCT05318365Not Applicable

Bladder and Bowel Dysfunction in Children

Recruiting
NCT02765256Phase 2

Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease

Completed
NCT04270019Phase 1

Polyethylene Glycol to Improve Sensation Following Digital Nerve Laceration

Withdrawn
NCT05726344Not Applicable

Lactulose vs. Polyethylene Glycol as Bowel Preparation for Colonoscopy in Adults

Completed
NCT03476317Phase 2

Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease

Completed
NCT03247595Not Applicable

Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy

Completed
NCT00770432Phase 4

Study Comparing PEG 3350 Laxative to Placebo in the Treatment of Occasional Constipation (Study CL2007-12)(P08216)

Completed
NCT03060512Phase 4

To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation

Completed
NCT02336906Phase 4

Urotherapy vs. Urotherapy With Constipation Treatment for Children With Lower Urinary Tract Dysfunction

Withdrawn
NCT02337413Phase 4

Urotherapy vs. Urotherapy With Constipation Treatment for Nocturnal Enuresis

Withdrawn
NCT02102373Not Applicable

Evaluation of Two Different Diet Regimen Prior to Colonoscopy in Children

Completed
NCT01566409Not Applicable

Maintenance Treatment for Children With Constipation

Completed
NCT01518790Not Applicable

Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children

Completed

Drug Details

Intervention Type
DRUG
Total Trials
21